Skip to main content
. 2001 Apr 3;98(8):4575–4580. doi: 10.1073/pnas.071055798

Figure 2.

Figure 2

Levels of ANX7 protein expression in a prostate cancer tissue microarray. (A) Loss of expression of ANX7 during prostate cancer progression. BPH: benign prostatic hyperplesia; PIN: high-grade prostatic intraepithelial neoplesia; stage T2: clinically localized primary cancer; stage T3/T4: locally advanced primary cancer; Hr loc re: hormone refractory local recurrence. (B) Representative sections of the hemotoxylin-eosin (H&E) and immunohistochemical staining of ANX7 protein using monoclonal anti-ANX7 antibody on the prostate cancer tissue microarray (original magnification: ×100).